RSK Substrate
The RSK sub peptide sequence (KRRRLSSLRA) is based on human 40S ribosomal protein S6 (amino acid 230-239).
Catalog No. S06-58
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| S06-58 | 1 mg | $83 | |
| S06-58-BULK | BULK | Contact Us |
The RSK sub peptide sequence (KRRRLSSLRA) is based on human 40S ribosomal protein S6 (amino acid 230-239).
Catalog No. S06-58
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| S06-58 | 1 mg | $83 | |
| S06-58-BULK | BULK | Contact Us |
No overview information available.
Purity:
Determined to be 95.1% by HPLC analysis.
Storage, Stability and Shipping:
Store product at –20oC. For optimal storage, aliquot diluted product into smaller quantities and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
1242.5
MJ Lommel et al., L-plastin Ser5 phosphorylation breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway. FASEB Journal March 2016 10.1096/fj.15-276311
M. Reipas Kristen et al., Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1). Oncotarget February 2014 10.18632/oncotarget.834
A. Everley Robert et al., Increasing Throughput in Targeted Proteomics Assays: 54-Plex Quantitation in a Single Mass Spectrometry Run Analytical Chemistry May 2013 10.1021/ac400845e
Apoptosis/Autophagy, Cancer, Cardiovascular Disease, ERK/MAPK Pathway, Inflammation, Neurobiology, NfkB Pathway, Ser/Thr Kinases
RSK3, Active, R16-10G
p70S6Kb, Active, R22-10G
RSK2 (I416V), Active, R17-12BG
RSK2 (L608F), Active, R17-12CG
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com